Refresh

This website fda.report/applications/211255 is currently offline. Cloudflare\'s Always Online™ shows a snapshot of this web page from the Internet Archive\'s Wayback Machine. To check for the live version, click Refresh.

ACTAVIS LABS FL INC FDA Approval ANDA 211255

ANDA 211255

ACTAVIS LABS FL INC

FDA Drug Application

Application #211255

Documents

Letter2022-08-01

Application Sponsors

ANDA 211255ACTAVIS LABS FL INC

Marketing Status

None (Tentative Approval)001

Application Products

001CAPSULE;ORAL72MCG0LINACLOTIDELINACLOTIDE

FDA Submissions

UNKNOWN; ORIG1TA2022-06-16STANDARD

Submissions Property Types

ORIG1Null31

CDER Filings

ACTAVIS LABS FL INC
cder:Array
(
    [0] => Array
        (
            [ApplNo] => 211255
            [companyName] => ACTAVIS LABS FL INC
            [docInserts] => ["",""]
            [products] => [{"drugName":"LINACLOTIDE","activeIngredients":"LINACLOTIDE","strength":"72MCG","dosageForm":"CAPSULE;ORAL","marketingStatus":"None (Tentative Approval)","te":"None","rld":"No","rs":"No"}]
            [labels] => 
            [originalApprovals] => [{"actionDate":"06\/16\/2022","submission":"ORIG-1","actionType":"Tentative Approval","submissionClassification":"","reviewPriority":"STANDARD","inserts":"[]","notes":"> Label is not available on this site."}]
            [supplements] => 
            [actionDate] => 2022-06-16
        )

)

© 2025 FDA.report
This site is not affiliated with or endorsed by the FDA.